These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23103568)

  • 1. Estrogen receptor signaling as a target for novel breast cancer therapeutics.
    Renoir JM; Marsaud V; Lazennec G
    Biochem Pharmacol; 2013 Feb; 85(4):449-65. PubMed ID: 23103568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol receptors in breast cancer cells: associated co-factors as targets for new therapeutic approaches.
    Renoir JM
    Steroids; 2012 Oct; 77(12):1249-61. PubMed ID: 22917634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
    Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
    Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
    Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor: current understanding of its activation and modulation.
    Osborne CK; Schiff R; Fuqua SA; Shou J
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4338s-4342s; discussion 4411s-4412s. PubMed ID: 11916222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor.
    Boonyaratanakornkit V
    Steroids; 2011 Aug; 76(9):877-84. PubMed ID: 21354435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-initiated steroid signaling action of estrogen and breast cancer.
    Song RX
    Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
    Saha T; Makar S; Swetha R; Gutti G; Singh SK
    Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.
    Fox EM; Andrade J; Shupnik MA
    Steroids; 2009 Jul; 74(7):622-7. PubMed ID: 18996136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities.
    Yan S; Ji J; Zhang Z; Imam M; Chen H; Zhang D; Wang J
    Biomed Pharmacother; 2024 Jun; 175():116615. PubMed ID: 38663101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of hormone resistance of breast cancer.
    Scherbakov AM; Krasil'nikov MA; Kushlinskii NE
    Bull Exp Biol Med; 2013 Jul; 155(3):384-95. PubMed ID: 24137610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor.
    Levin ER
    Mol Endocrinol; 2003 Mar; 17(3):309-17. PubMed ID: 12554774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane estrogen receptors - is it an alternative way of estrogen action?
    Soltysik K; Czekaj P
    J Physiol Pharmacol; 2013 Apr; 64(2):129-42. PubMed ID: 23756388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
    Krishnan AV; Swami S; Feldman D
    Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.